Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DAP000946

Drug Information
NameFenoterol
SynonymsFenoterolum; Prestwick1_000282; CHEMBL32800; 1944-10-1; L000255; Lopac0_000544; Benzyl alcohol, 3,5-dihydroxy-alpha-(((p-hydroxy-alpha-methylphenethyl)amino)methyl)-; Berotek; Berotec; BPBio1_000204; AC1L1FPW; BSPBio_000184; SPBio_002403; BRD-A97104540-004-04-4; Spectrum3_000915; DivK1c_000405; KBio2_001726; NINDS_000405; Spectrum4_001014; KBioGR_001507; Fenoterol (USAN/INN); TH 1165; Phenoterol; Fenoterol [USAN:BAN:INN]; LS-42858; Benzyl alcohol, 3,5-dihydroxy-.alpha.-(((p-hydroxy-.alpha.-methylphenethyl)amino)methyl)-; Prestwick3_000282; TH 1165A; KBioSS_001726; 1,3-Benzenediol, 5-(1-hydroxy-2-((2-(4-hydroxyphenyl)-1-methylethyl)amino)ethyl)-; KBio2_006862; DB01288; 13392-18-2; CID3343; 5-(1-hydroxy-2-{[1-(4-hydroxyphenyl)propan-2-yl]amino}ethyl)benzene-1,3-diol; CHEBI:149226; AB00053590; Th-1165a; 5-[1-hydroxy-2-[1-(4-hydroxyphenyl)propan-2-ylamino]ethyl]benzene-1,3-diol; Spectrum2_001388; 1944-12-3 (hydrobromide); Spectrum_001246; fenoterol; MolPort-002-052-088; BRN 2157041; KBio2_004294; 1-(p-Hydroxyphenyl)-2-((beta-hydroxy-beta-(3',5'-dihydroxyphenyl))ethyl)aminopropane; 5-(1-hydroxy-2-{[2-(4-hydroxyphenyl)-1-methylethyl]amino}ethyl)benzene-1,3-diol; SPBio_001376; 1-(3,5-Dihydroxyphenyl)-1-hydroxy-2-((4-hydroxyphenyl)isopropylamino)ethane; KBio1_000405; Prestwick2_000282; AC-13630; NCGC00162181-01; NCGC00015430-03; D04157; IDI1_000405; UNII-22M9P70OQ9; Prestwick0_000282; p-Hydroxyphenyl-orciprenaline; 5-{1-Hydroxy-2-[2-(4-hydroxy-phenyl)-1-methyl-ethylamino]-ethyl}-benzene-1,3-diol; Spectrum5_001572; Fenoterolum [INN-Latin]; KBio3_001890; AC1Q79W3; AR-1L6635; 3,5-Dihydroxy-alpha-(((p-hydroxy-alpha-methylphenethyl)amino)methyl)benzyl alcohol; p-Hydroxyphenylorciprenaline
Trade NameBerotec
CompanyBoehriger Ingelheim
IndicationAsthma
[ICD9: 493   ICD10: J45]
Approved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C17H21NO4/c1-11(6-12-2-4-14(19)5-3-12)18-10-17(22)13-7-15(20)9
-16(21)8-13/h2-5,7-9,11,17-22H,6,10H2,1H3
InChIKeyLSLYOANBFKQKPT-UHFFFAOYSA-N
Canonical SMILESCC(CC1=CC=C(C=C1)O)NCC(C2=CC(=CC(=C2)O)O)O    
Therapeutic ClassBronchodilator Agents
CAS NumberCAS 13392-18-2
FormulaC17H21NO4
PubChem Compound IDCID 3343.
PubChem Substance IDSID 168704.
SuperDrug ATC IDG02CA03; R03AC04; R03CC04
SuperDrug CAS ID013392182;
TargetBeta-2 adrenergic receptorAgonist[2][3]
Ref 1Acute clenbuterol overdose resulting in supraventricular tachycardia and atrial fibrillation. J Med Toxicol. 2007 Jun;3(2):56-60. To Reference
Ref 2Functional alpha1- and beta2-adrenergic receptors in human osteoblasts. J Cell Physiol. 2009 Jul;220(1):267-75. To Reference
Ref 3Effect of fenoterol-induced constitutive beta(2)-adrenoceptor activity on contractile receptor function in airway smooth muscle. Eur J Pharmacol. 2001 Nov 23;431(3):353-9. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543